Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Keywords: Arthritis, RA, DMARDs, Diagnosis, Pathophysiology, NSAIDs, TNF modifiers, Nutraceuticals
Rights & PermissionsPrintExport
Published on: 01 March, 2012
Page: [98 - 107]